Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9531 |
High Similarity |
NPD3027 |
Phase 3 |
0.9023 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.9023 |
High Similarity |
NPD1613 |
Approved |
0.8722 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8647 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8146 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8116 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8079 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8074 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8062 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.806 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8047 |
Intermediate Similarity |
NPD228 |
Approved |
0.8 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD37 |
Approved |
0.7943 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7935 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7877 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7815 |
Intermediate Similarity |
NPD1653 |
Approved |
0.781 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.781 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7801 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7785 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7752 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7752 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7681 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7607 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7593 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7536 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7536 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7534 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7534 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD3060 |
Approved |
0.75 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7445 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7431 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7405 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7397 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7397 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7372 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7344 |
Intermediate Similarity |
NPD846 |
Approved |
0.7344 |
Intermediate Similarity |
NPD940 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD290 |
Approved |
0.732 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7313 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7305 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7237 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7197 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6190 |
Approved |
0.719 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7188 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7162 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7126 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7125 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7107 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD943 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7075 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7071 |
Intermediate Similarity |
NPD5691 |
Approved |
0.707 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7054 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7051 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD27 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7047 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7042 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7021 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7021 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.702
|
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |